Literature DB >> 18566421

Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Matthew R Pipeling1, Erin E West, Christine M Osborne, Amanda B Whitlock, Lesia K Dropulic, Matthew H Willett, Michael Forman, Alexandra Valsamakis, Jonathan B Orens, David R Moller, Noah Lechtzin, Stephen A Migueles, Mark Connors, John F McDyer.   

Abstract

Acquisition of T cell responses during primary CMV infection in lung transplant recipients (LTRs) appear critical for host defense and allograft durability, with increased mortality in donor+/recipient- (D+R-) individuals. In 15 D+R- LTRs studied, acute primary CMV infection was characterized by viremia in the presence or absence of pneumonitis, with viral loads higher in the lung airways/allograft compared with the blood. A striking influx of CD8+ T cells into the lung airways/allograft was observed, with inversion of the CD4+:CD8+ T cell ratio. De novo CMV-specific CD8+ effector frequencies in response to pooled peptides of pp65 were strikingly higher in lung mononuclear cells compared with the PBMC and predominated over IE1-specific responses and CD4+ effector responses in both compartments. The frequencies of pp65-specific cytokine responses were significantly higher in lung mononuclear cells compared with PBMC and demonstrated marked contraction with long-term persistence of effector memory CD8+ T cells in the lung airways following primary infection. CMV-tetramer+CD8+ T cells from PBMC were CD45RA- during viremia and transitioned to CD45RA+ following resolution. In contrast, CMV-specific CD8+ effectors in the lung airways/allograft maintained a CD45RA- phenotype during transition from acute into chronic infection. Together, these data reveal differential CMV-specific CD8+ effector frequencies, immunodominance, and polyfunctional cytokine responses predominating in the lung airways/allograft compared with the blood during acute primary infection. Moreover, we show intercompartmental phenotypic differences in CMV-specific memory responses during the transition to chronic infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566421      PMCID: PMC2668691          DOI: 10.4049/jimmunol.181.1.546

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Preferential localization of effector memory cells in nonlymphoid tissue.

Authors:  D Masopust; V Vezys; A L Marzo; L Lefrançois
Journal:  Science       Date:  2001-03-01       Impact factor: 47.728

2.  Skewed maturation of memory HIV-specific CD8 T lymphocytes.

Authors:  P Champagne; G S Ogg; A S King; C Knabenhans; K Ellefsen; M Nobile; V Appay; G P Rizzardi; S Fleury; M Lipp; R Förster; S Rowland-Jones; R P Sékaly; A J McMichael; G Pantaleo
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Visualizing the generation of memory CD4 T cells in the whole body.

Authors:  R L Reinhardt; A Khoruts; R Merica; T Zell; M K Jenkins
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo.

Authors:  Christopher C Norbury; Daniela Malide; James S Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Nat Immunol       Date:  2002-02-04       Impact factor: 25.606

Review 5.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

Review 6.  Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.

Authors:  Jutta K Preiksaitis; Daniel C Brennan; Jay Fishman; Upton Allen
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

7.  Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.

Authors:  M T Roos; R A van Lier; D Hamann; G J Knol; I Verhoofstad; D van Baarle; F Miedema; P T Schellekens
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

Review 8.  Cytomegalovirus in solid organ transplantation.

Authors:  R H Rubin
Journal:  Transpl Infect Dis       Date:  2001       Impact factor: 2.228

9.  Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.

Authors:  K A Daniels; G Devora; W C Lai; C L O'Donnell; M Bennett; R M Welsh
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

10.  Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus.

Authors:  Scott N Mueller; Claerwen M Jones; Chris M Smith; William R Heath; Francis R Carbone
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  18 in total

1.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

2.  Early KLRG1+ but Not CD57+CD8+ T Cells in Primary Cytomegalovirus Infection Predict Effector Function and Viral Control.

Authors:  Aki Hoji; Iulia D Popescu; Matthew R Pipeling; Pali D Shah; Spencer A Winters; John F McDyer
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

Review 3.  Viral infections in lung transplant recipients.

Authors:  Pali Dedhiya Shah; John F McDyer
Journal:  Semin Respir Crit Care Med       Date:  2010-03-30       Impact factor: 3.119

4.  Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis.

Authors:  Pali D Shah; Qiong Zhong; Elizabeth A Lendermon; Matthew R Pipeling; John F McDyer
Journal:  Viral Immunol       Date:  2015-05-18       Impact factor: 2.257

5.  Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.

Authors:  Laurie D Snyder; Cliburn Chan; Darongsae Kwon; John S Yi; Jessica A Martissa; C Ashley Finlen Copeland; Robyn J Osborne; Sara D Sparks; Scott M Palmer; Kent J Weinhold
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

6.  T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.

Authors:  Iulia Popescu; Matthew R Pipeling; Pali D Shah; Jonathan B Orens; John F McDyer
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

7.  Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.

Authors:  Iulia Popescu; M Bradley Drummond; Lucio Gama; Tiffany Coon; Christian A Merlo; Robert A Wise; Janice E Clements; Gregory D Kirk; John F McDyer
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

8.  High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.

Authors:  J A Akulian; M R Pipeling; E R John; J B Orens; N Lechtzin; J F McDyer
Journal:  Am J Transplant       Date:  2012-09-27       Impact factor: 8.086

9.  Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.

Authors:  Meghan R Forster; Joanne Trgovcich; Peter Zimmerman; Alexander Chang; Cortland Miller; Paul Klenerman; Charles H Cook
Journal:  Antiviral Res       Date:  2009-12-11       Impact factor: 5.970

10.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.